Genistein-induced selection of primitive and committed BCR/ABL negative progenitors is associated with induction of apoptosis

被引：0
|
作者：
CarloStella, C
Dotti, G
Mangoni, L
Regazzi, E
Garau, D
Rizzo, MT
Savoldo, B
Almici, G
Rizzoli, V
机构：
[1] UNIV PARMA, DEPT HEMATOL, I-43100 PARMA, ITALY
[2] METHODIST CANC CTR, INDIANAPOLIS, IN USA
[3] METHODIST CANC CTR, INDIANAPOLIS, IN USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1996年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：627 / 627
页数：1
相关论文
共 18 条
  • [1] Genistein triggers apoptosis of chronic myelogenous leukemia cells and selects BCR/ABL negative progenitors.
    Rizzoli, V
    Regazzi, E
    Dotti, G
    Mangoni, L
    Garau, D
    Rizzo, MT
    Savoldo, B
    Bonati, A
    CarloStella, C
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 646 - 646
  • [2] Chronic myelogenous leukemia CD34(+) marrow cells lacking CD95 expression are enriched for BCR/ABL negative primitive and committed progenitors.
    CarloStella, C
    Savoldo, B
    Regazzi, E
    Garau, D
    Sammarelli, G
    Mangoni, L
    Almici, C
    Frassoni, F
    Rizzoli, V
    BLOOD, 1996, 88 (10) : 2284 - 2284
  • [3] In vitro selection of myeloid progenitors lacking BCR-ABL in chronic myelogenous leukemia patients after treatment with genistein.
    CarloStella, C
    Dotti, G
    Mangoni, L
    Regazzi, E
    Garau, D
    Rizzo, MT
    Savoldo, B
    Almici, C
    Rizzoli, V
    BLOOD, 1995, 86 (10) : 2395 - 2395
  • [4] Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein
    CarloStella, C
    Dotti, G
    Mangoni, L
    Regazzi, E
    Garau, D
    Bonati, A
    Almici, C
    Sammarelli, G
    Savoldo, B
    Rizzo, MT
    Rizzoli, V
    BLOOD, 1996, 88 (08) : 3091 - 3100
  • [5] Genistein-induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells
    Davis, JN
    Singh, B
    Bhuiyan, M
    Sarkar, FH
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1998, 32 (03): : 123 - 131
  • [6] Favorable therapeutic index of a p210BCR-ABL-specific tyrosine kinase inhibitor; activity on lineage-committed and primitive chronic myelogenous leukemia progenitors
    Bernd Kasper
    Stefan Fruehauf
    Bernd Schiedlmeier
    Elisabeth Buchdunger
    Anthony D. Ho
    W. Jens Zeller
    Cancer Chemotherapy and Pharmacology, 1999, 44 : 433 - 438
  • [7] Favorable therapeutic index of a p210BCR-ABL-specific tyrosine kinase inhibitor;: activity on lineage-committed and primitive chronic myelogenous leukemia progenitors
    Kasper, B
    Fruehauf, S
    Schiedlmeier, B
    Buchdunger, E
    Ho, AD
    Zeller, WJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 44 (05) : 433 - 438
  • [8] Potent induction of apoptosis by givinostat in BCR-ABL1-positive and BCR-ABL1-negative precursor B-cell acute lymphoblastic leukemia cell lines
    Yao, Chenjiao
    Zhang, Guojuan
    Walker, Alison
    Zhao, Kevin Y.
    Li, Ying
    Lyu, Lei
    Tang, Yan
    Ru, Peng
    Jones, Dan
    Zhao, Weiqiang
    LEUKEMIA RESEARCH, 2017, 60 : 129 - 134
  • [9] BCR-mediated apoptosis associated with negative selection of immature B cells is selectively dependent on Pten
    Shuhua Cheng
    Constance Yu Hsia
    Biao Feng
    Mei-Ling Liou
    Xiaoying Fang
    Pier Paolo Pandolfi
    Hsiou-Chi Liou
    Cell Research, 2009, 19 : 196 - 207
  • [10] BCR-mediated apoptosis associated with negative selection of immature B cells is selectively dependent on Pten
    Cheng, Shuhua
    Hsia, Constance Yu
    Feng, Biao
    Liou, Mei-Ling
    Fang, Xiaoying
    Pandolfi, Pier Paolo
    Liou, Hsiou-Chi
    CELL RESEARCH, 2009, 19 (02) : 196 - 207
12